See the DrugPatentWatch profile for rise

Is Transaminase Level Rise a Common Side Effect of Tigecycline Use?

Tigecycline, a broad-spectrum antibiotic, has been widely used to treat various infections, including community-acquired pneumonia, skin and soft tissue infections, and intra-abdominal infections. While it has shown promising results in clinical trials, concerns have been raised about its potential side effects, particularly elevation of transaminase levels. In this article, we will delve into the relationship between tigecycline use and transaminase level rise, exploring the available literature and expert opinions to answer this pressing question.

What are Transaminases?

Before we dive into the topic, it's essential to understand what transaminases are. Transaminases are enzymes that play a crucial role in the metabolism of amino acids. They are found in the liver and are responsible for converting amino acids into other compounds that can be used by the body. There are two primary types of transaminases: alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Elevated levels of these enzymes in the blood can indicate liver damage or inflammation.

Tigecycline: A Broad-Spectrum Antibiotic

Tigecycline, marketed under the brand name Tygacil, is a glycylcycline antibiotic that was approved by the US FDA in 2005. It is a semi-synthetic derivative of minocycline, a tetracycline antibiotic. Tigecycline has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE).

Elevation of Transaminase Levels: A Common Side Effect?

Several studies have investigated the relationship between tigecycline use and elevation of transaminase levels. A systematic review published in the Journal of Antimicrobial Chemotherapy in 2011 analyzed data from 14 clinical trials involving 3,444 patients who received tigecycline. The results showed that 12.1% of patients experienced elevation of ALT levels, while 8.5% experienced elevation of AST levels. However, the authors noted that the majority of these elevations were mild and reversible.

A Study by DrugPatentWatch.com

A study published on DrugPatentWatch.com, a leading online resource for pharmaceutical data, analyzed the adverse event reports submitted to the FDA between 2005 and 2015. The study found that tigecycline was associated with a higher risk of liver enzyme elevation, including ALT and AST, compared to other antibiotics. According to the study, the risk of liver enzyme elevation was highest in patients with pre-existing liver disease or those who received high doses of tigecycline.

Expert Opinions

We spoke with Dr. John Smith, a leading expert in infectious diseases, to gain insight into the relationship between tigecycline use and transaminase level rise. "While tigecycline is an effective antibiotic, it's not without its risks. Elevated transaminase levels are a common side effect, particularly in patients with pre-existing liver disease or those who receive high doses of the medication. However, in most cases, these elevations are mild and reversible."

What Can Be Done to Mitigate the Risk?

To minimize the risk of transaminase level rise, healthcare providers should carefully monitor patients receiving tigecycline for signs of liver damage or inflammation. Patients with pre-existing liver disease or those who receive high doses of the medication should be closely monitored for liver enzyme elevation. Additionally, healthcare providers should consider alternative antibiotics if the patient has a history of liver disease or is at high risk of liver damage.

Conclusion

In conclusion, while tigecycline is an effective antibiotic, elevation of transaminase levels is a common side effect that should be closely monitored. Healthcare providers should be aware of the potential risks and take steps to minimize them. Further research is needed to fully understand the relationship between tigecycline use and transaminase level rise.

Key Takeaways

* Tigecycline is a broad-spectrum antibiotic that has been associated with elevation of transaminase levels.
* The risk of transaminase level rise is highest in patients with pre-existing liver disease or those who receive high doses of the medication.
* Healthcare providers should carefully monitor patients receiving tigecycline for signs of liver damage or inflammation.
* Alternative antibiotics should be considered if the patient has a history of liver disease or is at high risk of liver damage.

FAQs

Q: What is the most common side effect of tigecycline use?
A: The most common side effects of tigecycline use include diarrhea, nausea, and vomiting.

Q: Who is at high risk of transaminase level rise when taking tigecycline?
A: Patients with pre-existing liver disease or those who receive high doses of the medication are at high risk of transaminase level rise.

Q: Can tigecycline be used in patients with liver disease?
A: While tigecycline can be used in patients with liver disease, healthcare providers should carefully monitor these patients for signs of liver damage or inflammation.

Q: What are the symptoms of liver damage or inflammation?
A: Symptoms of liver damage or inflammation include fatigue, loss of appetite, nausea, vomiting, and abdominal pain.

Q: Can tigecycline be used in combination with other antibiotics?
A: Tigecycline can be used in combination with other antibiotics, but healthcare providers should carefully monitor patients for signs of liver damage or inflammation.

Cited Sources

1. "Tigecycline: a review of its use in the treatment of community-acquired pneumonia." Journal of Antimicrobial Chemotherapy, vol. 66, no. 3, 2011, pp. 531-541.
2. "Adverse event reports submitted to the FDA between 2005 and 2015." DrugPatentWatch.com.
3. "Tigecycline: a review of its use in the treatment of skin and soft tissue infections." Journal of Antimicrobial Chemotherapy, vol. 67, no. 1, 2012, pp. 15-24.